Ishigaki, Island in Ishigaki, Okinawa, Japan

Tokyo [Japan], April 18 : Researchers are increasingly using the blood-brain barrier, which allows only certain molecules to pass from the blood into the brain, to get therapies into the brain after a stroke.The findings of the study published earlier this year in Molecular Therapy,Japanese researchers discovered that when antisense oligonucleotides are linked to a specific type of lipid known as -tocopherol, they are preferentially taken up from the blood into areas of stroke damage (TOC).Current stroke therapies are only effective if they are delivered within a short window of time, which limits their effectiveness in many patients. Many new therapies are being investigated that can be applied outside this short window of opportunity. One such therapy involves the use of antisense oligonucleotides, which can be targeted to increase the production of beneficial proteins after a stroke, for example, or to decrease the production of harmful proteins. However, getting these molecules into the right area at the right time can be difficult, something that the researchers at Tokyo Medical and Dental University wanted to address."We've recently developed an antisense oligonucleotide known as a DNA/RNA heteroduplex oligonucleotide, or HDO," says senior author of the study Takanori Yokota. "To see how different lipids affect the uptake of HDO in the brain, we linked it to either cholesterol or TOC and then injected it into the blood of mice who had been given an experimentally induced stroke in just one side of the brain."Unexpectedly, the TOC-linked molecules were observed at very high levels in the stroke-lesioned side of the brain only, whereas the cholesterol-linked molecules were high in both sides of the brain. This suggests that TOC specifically increases HDO uptake after stroke, while cholesterol does not. Furthermore, because HDO can be tailored to target different genes, it was used to silence a gene known to be beneficial in stroke. As expected, the researchers observed greater areas of stroke-related damage in the mice treated with this TOC-linked HDO."Together, our findings suggest that TOC-linked HDO is safe to use and is preferentially taken up and incorporated into cells in areas of stroke damage," said Yokota. "This delivery method is potentially very useful for the targeted up- or down-regulation of protein expression after stroke."Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

IshigakiFOLLOW

Ishigaki, Latest News

Chennai, April 23 Tamil Nadu Chief Minister M.K. Stalin will be visiting Japan, Singapore, and the UK on ... ...

Seoul, April 23 South Korean air carriers saw the number of international passengers spike 16-fold in the first ... ...

Tokyo [Japan], April 22 : Japan has turned on its missile interceptors and is getting ready to shoot down ... ...

Tokyo [Japan], April 22 : A subcommittee of the Japanese health ministry's Pharmaceutical Affairs and Food Station Council on ... ...

Tokyo [Japan], April 22 (/WAM): The International Fund of Agricultural Development (IFAD) will set up a new framework to ... ...

Okinawa [Japan], April 20 : According to Okinawa Institute of Science and Technology researchers, gut bacteria that break down ... ...

Tokyo [Japan], April 19 : Ryuji Kimura, 24, who was detained on suspicion of hurling an explosive device at ... ...

Tokyo [Japan], April 18 : Researchers are increasingly using the blood-brain barrier, which allows only certain molecules to pass ... ...